EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Dual liver metastases from advanced genital extramammary Paget's disease and sigmoid cancer: Gathering each disease status from serum cytokeratin 19 fragment and carcinoembryonic antigen

Himino Ashida iD, Keiko Manabe iD, Toshiyuki Wakatsuki, Yoko Shinno, Shin'ichi Shimizu, Kenji Asagoe

The Journal of Dermatology · 2023

DOI: 10.1111/1346-8138.16742 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Himino Ashida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Okayama Medical Center, Okayama, Japan. Hauptthemen laut MEDLINE: Genital Neoplasms, Male, Liver Neoplasms, Paget Disease, Extramammary, Sigmoid Neoplasms. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, Carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA) are useful tumor markers for extramammary Paget's disease (EMPD).1– 3 We present an EMPD patient in whom multiple liver metastases from both EMPD and sigmoid cancer developed. CEA and CYFRA were useful for predicting the disease status. A man in his 70s presented with genital invasive EMPD with inguinal and iliac lymph node (LN) metastases. He underwent palliative surgery (primary tumor resection, left inguinal lymph node dissection). He declined postoperative chemotherapy. Four months postsurgery, a hepatic portal LN metastasis developed. The serum CYFRA level had risen to 51.5 ng/mL but the serum CEA level was within normal range. Two months later, the hepatic portal LN had enlarged and the CYFRA level was elevated to 207 ng/mL. Monthly docetaxel monotherapy was started. After six docetaxel cycles, the hepatic portal LN size and the serum CYFRA level had decreased. However, liver metastases appeared and the serum CEA rose (Figure 1a). An endoscopic examination revealed sigmoid cancer. We performed a liver biopsy to diagnose the liver metastases' primary lesion. Histological and immunohistochemical findings showed a proliferation of two types of atypical cells. Colon cancer cells that were cytokeratin (CK)7(−), CK20(+), caudalrelated homeobox transcription factor 2 (CDX2) (+), and CEA(+) proliferated with luminal structures, and Paget cells that were CK7(+), CK20(−), CDX2(−), and CEA(−) proliferated, replacing hepatic parenchyma, suggesting the coexistence of metastatic colon cancer and metastatic EMPD (Figure 1b– h). We administered mFOLFOX6 therapy (oxaliplatin/5fluorouracil/ leucovorin) based on the suspicion that the elevated serum CEA level reflected the disease progression of colon cancer. Despite a partial decrease in the liver metastases' size, the serum CEA level continued to elevate. The patient's general condition worsened and he died 19 months postsurgery (Figure 1i). Carcinoembryonic antigen levels tend to elevate in patients with metastatic genital EMPD compared to those with nonmetastatic EMPD.4 Patients with nodal metastatic EMPD can show an elevated serum CYFRA level without CEA elevation.1,5 Our patient was diagnosed with invasive EMPD with nodal metastases at his initial visit. After docetaxel therapy, his hepatic portal LN metastasis and serum CYFRA level decreased, and we speculate that CYFRA, rather than CEA, reflected the tumor progression status of his EMPD. However, the serum CEA elevated markedly at the same time. We suspected that this discrepancy between the two tumor markers might have been caused by a selective proliferation of CEAexpressing EMPD tumor cells or the presence of another CEAproducing tumor. The patient was eventually revealed to have liver metastases and colon cancer. Additionally, the liver biopsy revealed dual metastases from both EMPD and colon cancer. In light of the patient's clinical course and immunohistochemical findings, it is likely that the CEA values reflected colon cancer progression. To the best of our knowledge, this is the first report of dual liver metastases from EMPD and sigmoid cancer. This case indicates that the combination of CYFRA and CEA was useful for determining disease status. When a patient's tumor markers are shifting, the existence of a second cancer should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, MaleLiver NeoplasmsPaget Disease, ExtramammarySigmoid NeoplasmsHumansMaleCarcinoembryonic AntigenGenitaliaKeratin-19Aged

Substanzen

Carcinoembryonic AntigenKeratin-19

Autor:innen und Institutionen

  • Department of Dermatology, Okayama Medical Center, Okayama, Japan.
  • Department of Dermatology, Takamatsu Red Cross Hospital, Takamatsu, Japan.
  • Department of Gastroenterological Medicine, Okayama Medical Center, Okayama, Japan.
  • Department of Pathology, Okayama Medical Center, Okayama, Japan.

ORCID-Profile: Himino Ashida, Keiko Manabe

Zitieren

APA

Ashida, H., Manabe, K., Wakatsuki, T., Shinno, Y., Shimizu, S., & Asagoe, K. (2023). Dual liver metastases from advanced genital extramammary Paget's disease and sigmoid cancer: Gathering each disease status from serum cytokeratin 19 fragment and carcinoembryonic antigen. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16742

Vancouver

Ashida H, Manabe K, Wakatsuki T, Shinno Y, Shimizu S, Asagoe K. Dual liver metastases from advanced genital extramammary Paget's disease and sigmoid cancer: Gathering each disease status from serum cytokeratin 19 fragment and carcinoembryonic antigen. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16742

BibTeX
@article{Ashida2023,
  author = {Ashida, Himino and Manabe, Keiko and Wakatsuki, Toshiyuki and Shinno, Yoko and Shimizu, Shin'ichi and Asagoe, Kenji},
  title = {Dual liver metastases from advanced genital extramammary Paget's disease and sigmoid cancer: Gathering each disease status from serum cytokeratin 19 fragment and carcinoembryonic antigen},
  journal = {The Journal of Dermatology},
  year = {2023},
  doi = {10.1111/1346-8138.16742}
}
Kostenlos starten →